Rachel Smith | Global Head, Rare Disease
Parexel

Rachel has more than 10 years of experience in all development phases of rare disease and cell and gene therapy clinical trials. Rachel is an ultra-rare disease subject matter expert with oversight of 30+ orphan programs in APAC, Europe and North America. She is a specialist in clinical development strategy, novel and adaptive trial design, decentralized trials and creative solutions for rare disease and products with a non-classical route to market. Prior to joining Parexel, Rachel was VP European Clinical Operations, Global Head of Cell & Gene Center of Excellence and Portfolio Director in Rare Disease at Veristat LLC.